Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 1 951.5 INR -0.13% Market Closed
Market Cap: 148.3B INR
Have any thoughts about
Caplin Point Laboratories Ltd?
Write Note

Caplin Point Laboratories Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Caplin Point Laboratories Ltd
Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Revenue
â‚ą17.6B
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
26%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
â‚ą289.5B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
â‚ą265.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
â‚ą503.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
â‚ą112.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Revenue
â‚ą103.3B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Caplin Point Laboratories Ltd's Revenue?
Revenue
17.6B INR

Based on the financial report for Jun 30, 2024, Caplin Point Laboratories Ltd's Revenue amounts to 17.6B INR.

What is Caplin Point Laboratories Ltd's Revenue growth rate?
Revenue CAGR 10Y
26%

Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Caplin Point Laboratories Ltd have been 16% over the past three years , 20% over the past five years , and 26% over the past ten years .

Back to Top